Multiplex assay for genetic testing of thrombophilia: a method for routine clinical care
暂无分享,去创建一个
José Manuel Soria | Mónica López | R Cornudella | Pilar Giraldo | J. Fontcuberta | J. Soria | Jordi Fontcuberta | R. Cornudella | Miguel Pocoví | M. Pocovi | P. Giraldo | Patricia Alvarez | Antonio Martínez | Patricia Alvarez | Antonio Martínez | Mónica López
[1] M. Verstraete,et al. A European view on the North American fifth consensus on antithrombotic therapy. , 2000, Chest.
[2] J. Fontcuberta,et al. New approaches and future prospects for evaluating genetic risk of thrombosis. , 2005, Haematologica.
[3] L. Almasy,et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. , 2000, American journal of human genetics.
[4] F. Marín,et al. Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction. , 2005, Haematologica.
[5] A. Lanthaler,et al. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR. , 1999, Haematologica.
[6] P. Reitsma,et al. Resistance to Activated Protein C and Factor V Leiden as Risk Factors for Venous Thrombosis , 1995, Thrombosis and Haemostasis.
[7] B. Dahlbäck,et al. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. , 1995, Blood.
[8] J. Fontcuberta,et al. Association after linkage analysis indicates that homozygosity for the 46C→T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis , 2004, Thrombosis and Haemostasis.
[9] L. Drouet,et al. Multiplex PCR-mediated Site-directed Mutagenesis for One-step Determination of Factor V Leiden and G20210A Transition of the Prothrombin Gene , 1997, Thrombosis and Haemostasis.
[10] J. Fontcuberta,et al. Rapid detection of the 46C --> T polymorphism in the factor XII gene, a novel genetic risk factor for thrombosis, by melting peak analysis using fluorescence hybridization probes. , 2003, Genetic testing.
[11] A. Zivelin,et al. Thrombophilia as a Multigenic Disorder , 1997, Thrombosis and Haemostasis.
[12] K. Livak,et al. A homogeneous, ligase-mediated DNA diagnostic test. , 1998, Genome research.
[13] J. Fontcuberta,et al. Homozygosity of the T allele of the 46 C-->T polymorphism in the F12 gene is a risk factor for acute coronary artery disease in the Spanish population. , 2004, Haematologica.
[14] P. Reitsma,et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. , 1994 .
[15] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[16] B. Lindblad,et al. A prospective study of the incidence of deep‐vein thrombosis within a defined urban population , 1992, Journal of internal medicine.
[17] J. Wisotzkey,et al. Simultaneous Polymerase Chain Reaction Restriction Fragment Length Polymorphism Identification of the Factor V Leiden Allele and the Prothrombin 20210A Mutation , 1998, Diagnostic molecular pathology (Print).
[18] Muin J Khoury,et al. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. , 2003, American journal of human genetics.
[19] V. Armstrong,et al. Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. , 1999, Clinical chemistry.
[20] M. Powell,et al. Detection of the hereditary hemochromatosis gene mutation by real-time fluorescence polymerase chain reaction and peptide nucleic acid clamping. , 1998, Analytical biochemistry.
[21] Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms. , 1999, Thrombosis research.
[22] D. Hosmer,et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.
[23] D. Dawson,et al. Development of a simple multiplex polymerase chain reaction for the simultaneous detection of factor V Leiden and prothrombin 20210A mutations. , 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.
[24] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[25] J. Martí-Fàbregas,et al. Homozygosity of the T Allele of the 46 C→T Polymorphism in the F12 Gene Is a Risk Factor for Ischemic Stroke in the Spanish Population , 2004, Stroke.
[26] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[27] G. Muriel,et al. An even easier method for one-step detection of both FV Leiden and FII G20210A transition. , 1998, Blood.
[28] J. Keller,et al. Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study , 1973, Circulation.
[29] Fred Russell Kramer,et al. Spectral Genotyping of Human Alleles , 1998, Science.
[30] P. Reitsma,et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) , 1995, Blood.
[31] L. Almasy,et al. A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. , 2002, American journal of human genetics.
[32] P. Mannucci,et al. Inherited Thrombophilia: Part 1 , 1996, Thrombosis and Haemostasis.
[33] J. Fontcuberta,et al. The Prothrombin 20210A Allele Is the Most Prevalent Genetic Risk Factor for Venous Thromboembolism in the Spanish Population , 1998, Thrombosis and Haemostasis.